What does infusion technology — goodwill impairment mean?

Represents the non-cash charge recognized when the carrying value of goodwill associated with the Infusion Technology segment exceeds its implied fair value. This indicates a decline in the expected future economic benefits of the acquired assets within this business unit. Investors monitor this to assess the success of past acquisitions and the current valuation of segment-specific intangible assets.

Rafael Holdings, Inc. RFL Infusion Technology — Goodwill Impairment

Similar metrics at other companies

INVTechnology — Goodwill impairment

$0-100%

LYBTechnology — Goodwill impairments

$0—

KFRCTechnology — Goodwill, Impaired, Accumulated Impairment Loss

$139.36M0.0%

TLRYBeverage — Goodwill Impairment

$100M0.0%

ASYSThermal Processing Solutions — Goodwill Impairment

$0-100%

TLSImpairment loss on intangible assets — Goodwill impairment

$3.73M—

Other financials

Income statement

See full

Revenue$179.0K-50.6%

Gross profit$131.0K-56.3%

Operating income-$6.9M-16.2%

Net income-$4.2M+11.6%

EPS (diluted)-$0.08+57.9%

Balance sheet

See full

Cash & equivalents$30.5M-19.6%

Total debt$21.9M+995%

Total equity$75.4M-6.4%

Total assets$92.0M-14.9%

Cash flow

See full

Operating cash flow-$7.3M-128%

CapEx$6.0K—

Free cash flow-$7.3M-128%

Valuation

See full

Market cap$170.56M+189%

P/S174×+93.5×

Profitability

See full

Gross margin71.9%—

Operating margin-3,717.2%+1,952pp

Net margin-2,117.2%-517pp

FCF margin-2,064.1%—

Returns & leverage

See full

Return on equity-26.6%-0.8pp

Debt / equity0.3×+0.2×

Current ratio3.2×-0.7×

Where this comes from

Reported directly by Rafael Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.

The official record: Rafael Holdings, Inc.’s 10-Q, filed March 16, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rafael Holdings, Inc.'s infusion technology — goodwill impairment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rafael Holdings, Inc.'s infusion technology — goodwill impairment?: Rafael Holdings, Inc. (RFL) reported infusion technology — goodwill impairment of $3.05M in Q4 2024.
What does infusion technology — goodwill impairment mean?: Represents the non-cash charge recognized when the carrying value of goodwill associated with the Infusion Technology segment exceeds its implied fair value. This indicates a decline in the expected future economic benefits of the acquired assets within this business unit. Investors monitor this to assess the success of past acquisitions and the current valuation of segment-specific intangible assets.